| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Jun-08 | | Total Revenue | 193,195 | 205,368 | 264,926 | 664,141 | | Cost of Revenue | 54,603 | 63,062 | 113,250 | 230,520 | | | Gross Profit | 138,592 | 142,306 | 151,676 | 433,621 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 123,601 | 167,201 | 87,068 | 242,688 | | Non Recurring | 218,433 | 1,493 | 60,977 | 776,536 | | Others | (205,965) | 228,514 | 12,214 | 29,703 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,523 | (254,902) | (8,583) | (615,306) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (230) | (1,028) | (24,639) | (113,949) | | Earnings Before Interest And Taxes | 2,924 | (256,349) | (19,427) | (721,712) | | Interest Expense | 163 | 246 | (58) | 4,874 | | Income Before Tax | 2,761 | (256,595) | (19,369) | (726,586) | | Income Tax Expense | 508 | (35,748) | (7,784) | (219,786) | | Minority Interest | 147 |
-
| 111 | (24,441) | | | | Net Income From Continuing Ops | 2,400 | (220,847) | (11,474) | (531,241) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (1,144) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,400 | (220,847) | (12,618) | (531,241) | | Preferred Stock And Other Adjustments | (147) | 147 |
-
|
-
| | | Net Income Applicable To Common Shares | $2,253 | ($220,700) | ($12,618) | ($531,241) |
|
2.03% Nasdaq 
Income Statement
